Effects of growth hormone and free fatty acids on insulin sensitivity in patients with type 1 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 9, 2009, Pages 3297-3305

  Salgin, Burak ^a,d   Marcovecchio, Maria L ^a   Williams, Rachel M ^a   Jackson, Sarah J ^b   Bluck, Leslie J ^b   Humphreys, Sandy M ^c   Acerini, Carlo L ^a   Dunger, David B ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACIPIMOX; FATTY ACID; GLUCOSE; GLYCEROL; GROWTH HORMONE; INSULIN; NEUTRAL INSULIN; OCTREOTIDE; PLACEBO; RECOMBINANT GROWTH HORMONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FATTY ACID BLOOD LEVEL; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HORMONE SYNTHESIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOLYSIS; MALE; PRIORITY JOURNAL; TURNOVER TIME;

EID: 69949103177     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0378     Document Type: Article

References (51)

1. Greenbaum CJ 2002 Insulin resistance in type 1 diabetes. Diabetes Metab Res Rev 18:192-200
2. Edge JA, Matthews DR, Dunger DB 1990 Failure of current insulin regimes to meet the overnight requirements of adolescents with insulin-dependent diabetes. Diabetes Res 15:109-112
3. Ahmed ML, Ong KK, Watts AP, Morrell DJ, Preece MA, Dunger DB 2001 Elevated leptin levels are associated with excess gains in fat mass in girls, but not boys, with type 1 diabetes: longitudinal study during adolescence. J Clin Endocrinol Metab 86:1188-1193
4. Edge JA, Dunger DB, Matthews DR, Gilbert JP, Smith CP 1990 Increased overnight growth hormone concentrations in diabetic compared with normal adolescents. J Clin Endocrinol Metab 71:1356-1362 (Pubitemid 20386345)
5. Edge JA, Matthews DR, Dunger DB 1990 The dawn phenomenon is related to overnight growth hormone release in adolescent diabetics. Clin Endocrinol (Oxf) 33:729-737
6. Pal BR, Matthews DR, Edge JA, Mullis PE, Hindmarsh PC, Dunger DB 1993 The frequency and amplitude of growth hormone secretory episodes as determined by deconvolution analysis are increased in adolescents with insulin dependent diabetes mellitus and are unaffected by short-term euglycaemia. Clin Endocrinol (Oxf) 38:93-100
7. Wurzburger MI, Sonksen PH 1996 Natural course of growth hormone hypersecretion in insulin-dependent diabetes mellitus. Med Hypotheses 46:145-149 (Pubitemid 26075777)
8. Boni-Schnetzler M, Schmid C, Meier PJ, Froesch ER 1991 Insulin regulates insulin-like growth factor I mRNA in rat hepatocytes. Am J Physiol 260:E846-E851
9. Baxter RC, Bryson JM, Turtle JR 1980 Somatogenic receptors of rat liver: regulation by insulin. Endocrinology 107:1176-1181 (Pubitemid 10019113)
10. Lee PD, Conover CA, Powell DR 1993 Regulation and function of insulin-like growth factor-binding protein-1. Proc Soc Exp Biol Med 204:4-29 (Pubitemid 23274051)
11. Shishko PI, Kovalev PA, Goncharov VG, Zajarny IU 1992 Comparison of peripheral and portal (via the umbilical vein) routes of insulin infusion in IDDM patients. Diabetes 41:1042-1049
12. Rizza RA, Mandarino LJ, Gerich JE 1982 Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 31:663-669
13. Bratusch-Marrain PR, Smith D, DeFronzo RA 1982 The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab 55:973-982
14. Dominici FP, Argentino DP, Munoz MC, Miquet JG, Sotelo AI, Turyn D 2005 Influence of the crosstalk between growth hormone and insulin signalling on the modulation of insulin sensitivity. Growth Horm IGF Res 15:324-336 (Pubitemid 41403767)
15. Nielsen C, Gormsen LC, Jessen N, Pedersen SB, Moller N, Lund S, Jorgensen JO 2008 Growth hormone signaling in vivo in human muscle and adipose tissue: impact of insulin, substrate background, and growth hormone receptor blockade. J Clin Endocrinol Metab 93:2842-2850 (Pubitemid 352008560)
16. Norrelund H 2005 The metabolic role of growth hormone in humans with particular reference to fasting. Growth Horm IGF Res 15:95-122 (Pubitemid 40443811)
17. Neely RD, Rooney DP, Bell PM, Bell NP, Sheridan B, Atkinson AB, Trimble ER 1992 Influence of growth hormone on glucose-glucose 6-phosphate cycle and insulin action in normal humans. Am J Physiol 263:E980-E987
18. Piatti PM, Monti LD, Caumo A, Conti M, Magni F, Galli-Kienle M, Fochesato E, Pizzini A, Baldi L, Valsecchi G, Pontiroli AE 1999 Mediation of the hepatic effects of growth hormone by its lipolytic activity. J Clin Endocrinol Metab 84:1658-1663 (Pubitemid 30644271)
19. Krag MB, Gormsen LC, Guo Z, Christiansen JS, Jensen MD, Nielsen S, Jorgensen JO 2007 Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics. Am J Physiol Endocrinol Metab 292:E920-E927 (Pubitemid 46411073)
20. Norrelund H, Nielsen S, Christiansen JS, Jorgensen JO, Moller N 2004 Modulation of basal glucose metabolism and insulin sensitivity by growth hormone and free fatty acids during short-term fasting. Eur J Endocrinol 150:779-787 (Pubitemid 38961650)
21. Segerlantz M, Bramnert M, Manhem P, Laurila E, Groop LC 2003 Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults. Eur J Endocrinol 149:511-519 (Pubitemid 38054694)
22. Nielsen S, Moller N, Christiansen JS, Jorgensen JO 2001 Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure. Diabetes 50:2301-2308 (Pubitemid 33641915)
23. Debodo RC, Steele R, Altszuler N, Dunn A, Bishop JS 1963 On the hormonal regulation of carbohydrate metabolism: studies with C14 glucose. Recent Prog Horm Res 19:445-488
24. Steele R 1959 Influences of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 82:420-430
25. Bluck LJC, Coward WA 1997 Peak measurement in gas chromatographic/mass spectrometric isotope studies. J Mass Spectrom 32:1212-1218 (Pubitemid 27479090)
26. Rabinowitz D, Klassen GA, Zierler KL 1965 Effect of human growth hormone on muscle and adipose tissue metabolism in the forearm of man. J Clin Invest 44:51-61
27. Moller N, Jorgensen JO, Schmitz O, Moller J, Christiansen J, Alberti KG, OrskovH1990 Effects of a growth hormone pulse on total and forearm substrate fluxes in humans. Am J Physiol 258:E86-E91
28. Moller N, Butler PC, Antsiferov MA, Alberti KG 1989 Effects of growth hormone on insulin sensitivity and forearm metabolism in normal man. Diabetologia 32:105-110 (Pubitemid 19096382)
29. Moller N, Schmitz O, Moller J, Butler PC 1992 Effects of a physiological growth hormone pulse on substrate metabolism in insulin-dependent (type 1) diabetic subjects. J Clin Endocrinol Metab 75:432-436
30. Simpson HL, Jackson NC, Shojaee-Moradie F, Jones RH, Russell-Jones DL, Sonksen PH, Dunger DB, Umpleby AM 2004 Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes. J Clin Endocrinol Metab 89:425-432 (Pubitemid 38185880)
31. Kahn CR, Goldfine ID, Neville Jr DM, De Meyts P 1978 Alterations in insulin binding induced by changes in vivo in the levels of glucocorticoids and growth hormone. Endocrinology 103:1054-1066
32. Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA 1983 Effect of fatty acids on glucose production and utilization in man. J Clin Invest 72:1737-1747 (Pubitemid 14229053)
33. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI 1996 Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97:2859-2865 (Pubitemid 26197099)
34. Boden G, Chen X, Ruiz J, White JV, Rossetti L 1994 Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93:2438-2446 (Pubitemid 24177157)
35. Rigazio S, Lehto HR, Tuunanen H, Nagren K, Kankaanpaa M, Simi C, Borra R, Naum AG, Parkkola R, Knuuti J, Nuutila P, Iozzo P 2008 The lowering of hepatic fatty acid uptake improves liver function and insulin sensitivity without affecting hepatic fat content in humans. Am J Physiol Endocrinol Metab 295:E413-E419
36. Gormsen LC, Jessen N, Gjedsted J, Gjedde S, Norrelund H, Lund S, Christiansen JS, Nielsen S, Schmitz O, Moller N 2007 Dose-response effects of free fatty acids on glucose and lipid metabolism during somatostatin blockade of growth hormone and insulin in humans. J Clin Endocrinol Metab 92:1834-1842 (Pubitemid 46997197)
37. Santomauro AT, Boden G, Silva ME, Rocha DM, Santos RF, Ursich MJ, Strassmann PG, Wajchenberg BL 1999 Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes 48:1836-1841 (Pubitemid 29415205)
38. Cusi K, Kashyap S, Gastaldelli A, Bajaj M, Cersosimo E 2007 Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes. Am J Physiol Endocrinol Metab 292:E1775-E1781 (Pubitemid 47084713)
39. Bajaj M, Medina-Navarro R, Suraamornkul S, Meyer C, DeFronzo RA, Mandarino LJ 2007 Paradoxical changes in muscle gene expression in insulin-resistant subjects after sustained reduction in plasma free fatty acid concentration. Diabetes 56:743-752 (Pubitemid 46348479)
40. Bajaj M, Suraamornkul S, Romanelli A, Cline GW, Mandarino LJ, Shulman GI, DeFronzo RA 2005 Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients. Diabetes 54:3148-3153 (Pubitemid 43334368)
41. Worm D, Vinten J, Vaag A, Henriksen JE, Beck-Nielsen H 2000 The nicotinic acid analogue acipimox increases plasma leptin and decreases free fatty acids in type 2 diabetic patients. Eur J Endocrinol 143:389-395
42. Worm D, Henriksen JE, Vaag A, Thye-Ronn P, Melander A, Beck-Nielsen H 1994 Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3-day intensified treatment period. J Clin Endocrinol Metab 78:717-721 (Pubitemid 24083317)
43. Carlson LA, Oro L 1962 The effect of nicotinic acid on the plasma free fatty acid; demonstration of a metabolic type of sympathicolysis. Acta Med Scand 172:641-645
44. Pinter EJ, Pattee CJ 1967 Biphasic nature of blood glucose and free fatty acid changes following intravenous nicotinic acid in man. J Clin Endocrinol Metab 27:440-443
45. Wang W, Basinger A, Neese RA, Shane B, Myong SA, Christiansen M, Hellerstein MK 2001 Effect of nicotinic acid administration on hepatic very low density lipoprotein-triglyceride production. Am J Physiol Endocrinol Metab 280:E540-E547 (Pubitemid 33780173)
46. Saloranta C, Taskinen MR, Widen E, Harkonen M, Melander A, Groop L 1993 Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM. Diabetes 42:1559-1566 (Pubitemid 23318110)
47. Lanes R, Recker B, Fort P, Lifshitz F 1985 Impaired somatomedin generation test in children with insulin-dependent diabetes mellitus. Diabetes 34:156-160 (Pubitemid 15155965)
48. Wurzburger MI, Prelevic GM, Sonksen PH, Wheeler M, Balint-Peric L 1995 Effect of recombinant human growth hormone treatment on insulin-like growth factor (IGF-I) levels in insulin-dependent diabetic patients. Acta Diabetol 32:131-134
49. Finegood DT, Bergman RN, Vranic M 1988 Modeling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps. Diabetes 37:1025-1034 (Pubitemid 19033580)
50. Levy JC, Brown G, Matthews DR, Turner RC 1989 Hepatic glucose output in humans measured with labeled glucose to reduce negative errors. Am J Physiol 257:E531-E540
51. Williams RM, Amin R, Shojaee-Moradie F, Umpleby AM, Acerini CL, Dunger DB 2003 The effects of a specific growth hormone antagonist on overnight insulin requirements and insulin sensitivity in young adults with type 1 diabetes mellitus. Diabetologia 46:1203-1210 (Pubitemid 37214978)